Dietary Treatment of Type V Hyperlipoproteinemia Fails to Normalize Low Levels of High-Density Lipoprotein Cholesterol

  1. JAMES M. FALKO, M.D.;
  2. JOSEPH L. WITZTUM, M.D.;
  3. GUSTAV SCHONFELD, M.D.; and
  4. JOYCE BATEMAN, R.D.
  1. Lipid Research Center, Department of Preventive Medicine, Washington University School of Medicine;
    St. Louis, Missouri

    Excerpt

    Recent epidemiologic and experimental data suggest that high-density lipoproteins may protect against the development of atherosclerosis (1, 2). Cross-sectional population studies have shown that plasma triglyceride values are inversely related to high-density lipoprotein-cholesterol values in both normal and hyperlipidemic populations (3). This has led to the suggestion that therapeutic lowering of plasma triglyceride levels would result in elevation of high-density lipoprotein-cholesterol levels. However, in a prospective longitudinal study of subjects with type IV hyperlipoproteinemia, we have shown that hypocaloric diet-induced normalization of plasma triglyceride levels failed to correct their initially low high-density lipoprotein-cholesterol values (4). In contrast, in response to

    Article and Author Information

    • The authors appreciate the assistance of the Lipid Research Clinic staff and the Core Laboratory.

    • Supported in part by NIH Contract N01-HV-2-2916-L (Lipid Research Clinics Program). Dr. Falko was supported by U.S. Public Health Service Training Grant 1F32-HL05566-01.

    « Previous | Next Article »Table of Contents